Davide Bimbatti Selected Research

Davide Bimbatti Research Topics

Disease

16	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 04/2015
10	Neoplasms (Cancer) 10/2022 - 10/2016
8	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2015
2	Kidney Neoplasms (Kidney Cancer) 10/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2021
2	Cardiotoxicity 01/2019 - 01/2018
1	Melanoma (Melanoma, Malignant) 02/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022
1	Pain (Aches) 12/2020
1	Frailty 10/2020
1	Carcinoma (Carcinomatosis) 02/2019
1	Left Ventricular Dysfunction 01/2019
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Metabolic Diseases (Metabolic Disease) 11/2015
1	Synovial Sarcoma (Synovioma) 11/2015
1	Hypertriglyceridemia 11/2015
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2015

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 10/2022 - 11/2018
5	cabozantinibIBA 10/2022 - 01/2019
4	NivolumabIBA 10/2022 - 01/2021
3	enzalutamideIBA 10/2020 - 01/2015
3	abirateroneIBA 10/2020 - 01/2018
2	Sunitinib (Sutent)FDA Link 01/2021 - 04/2015
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
2	Hormones (Hormone)IBA 10/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2015
1	IpilimumabIBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	Angiogenesis InhibitorsIBA 01/2021
1	pazopanib FDA Link 01/2021
1	tivozanibIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 12/2020
1	PlatinumIBA 02/2019
1	B7-H1 AntigenIBA 01/2019
1	AndrogensIBA 10/2018
1	Docetaxel (Taxotere)FDA Link 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Platinum Compounds (Compounds, Platinum)IBA 10/2016
1	Pharmaceutical PreparationsIBA 10/2016
1	Biological ProductsIBA 10/2016
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 10/2016
1	Adenosine Diphosphate (ADP)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Epidermal Growth Factor (EGF)IBA 11/2015
1	Oxygen (Dioxygen)IBA 11/2015
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2015
1	Fibrinogen (Factor I)FDA Link 11/2015
1	Fumarate Hydratase (Fumarase)IBA 11/2015
1	Ferritins (Ferritin)IBA 11/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	Abiraterone AcetateIBA 01/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2015

Therapy/Procedure

10	Therapeutics 10/2022 - 04/2015
7	Castration 12/2020 - 01/2015
5	Immunotherapy 01/2021 - 11/2018
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2015
1	Retreatment 02/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Duration of Therapy 01/2017
1	Precision Medicine 10/2016